Avilamycin A

• UNSPSC Description:

  Avilamycin A is an oral active antibiotic. Avilamycin A is active against veterinary isolates of C. perfringens (MICs ≤ 0.06-0.5 mg/L) and B. hyodysenteriae (MICs = 12.5-100 μg/ml)[1].

• Target Antigen:

  Antibiotic; Bacterial

• Type:

  Natural Products

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/avilamycin-a.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O[C@H]1[C@@H]([C@H](OC(O[C@@H]2[C@H](O[C@H](C3)O[C@H]4[C@@H](OC)[C@@H](C)O[C@@H](O[C@H]5[C@H](O)[C@H](OC)[C@H](O[C@@H]6OC[C@@H]7O[C@]8(O[C@H]7[C@H]6OC(C(C)C)=O)O[C@H](C)[C@@]([C@@H]9OCO[C@H]98)(O)C(C)=O)O[C@@H]5COC)[C@@H]4O)C)(C1)O[C@@]23C)C)O[C@@H]%10O[C@@H]([C@H]([C@@H](C%10)O)OC(C%11=C(C(Cl)=C(C(Cl)=C%11OC)O)C)=O)C

• Molecular Weight:

  1404.24

• References & Citations:

  [1]NGabriele Weitnauer, et al. Novel avilamycin derivatives with improved polarity generated by targeted gene disruption. Chem Biol. 2004 Oct;11(10):1403-11.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  69787-79-7